EUVIMEDEUVIMED entdecken
Crossref

Application of Gene-Directed Enzyme Prodrug Therapy in Cancer Treatment

Cindy Yeoh Shin Ly, Anil Philip Kunnath

International Journal of Biomedical Research & Practice · 2021

DOI: 10.33425/2769-6294.1004 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Biomedical Research & Practice, 2021. Verfasst von Cindy Yeoh Shin Ly und 1 weiteren Autor:innen. Die Arbeit wurde bisher 1-mal zitiert (Crossref).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Gene-directed enzyme prodrug therapy (GDEPT) is an advanced cancer therapy that has potential use against localized and metastasized cancer. This strategy aims to improve the limitations of chemotherapy and existing cancer treatments by specific gene delivery, which allows the conversion of systemically administered nontoxic prodrugs to active chemotherapeutic drugs inside the target tumor cells, thereby resulting in a significant therapeutic index by introducing high concentrations of cytotoxic compounds to the tumor cells while limiting the systemic toxicity. The main attraction of GDEPT is by expanding the toxicity to adjacent non-expressing target cancer cells through local and distal bystander effects, leading to tumor regression. This review focused on the application of the six main GDEPT systems for treating cancer, including herpes simplex virus thymidine kinase (HSV-TK) with ganciclovir (GCV), cytosine deaminase (CD) from bacteria or yeast with 5-fluorocytosine (5-FC), E. coli nitroreductase (NfsB) with 5-(aziridin-1-yl)-2,4- initrobenzamide (CB1954), hepatic cytochrome P4l50 (CYP450) with cyclophosphamide (CPA), purine nucleoside phosphorylase (PNP) from E. coli with 6-methylpurine deoxyriboside (MEP), and bacterial carboxypeptidase G2 (CPG2) with 4-[(2-chloroethyl)(2-mesloxyethyl)amino] benzoyl-L-glutamic acid (CMDA). In each system, the mechanism of action, clinical trials for the past decades, limitations, and areas that need improvement are discussed.

Zitieren

APA

Ly, C. Y. S., & Kunnath, A. P. (2021). Application of Gene-Directed Enzyme Prodrug Therapy in Cancer Treatment. International Journal of Biomedical Research & Practice. https://doi.org/10.33425/2769-6294.1004

Vancouver

Ly CYS, Kunnath AP. Application of Gene-Directed Enzyme Prodrug Therapy in Cancer Treatment. International Journal of Biomedical Research & Practice. 2021. doi:10.33425/2769-6294.1004

BibTeX
@article{Ly2021,
  author = {Ly, Cindy Yeoh Shin and Kunnath, Anil Philip},
  title = {Application of Gene-Directed Enzyme Prodrug Therapy in Cancer Treatment},
  journal = {International Journal of Biomedical Research & Practice},
  year = {2021},
  doi = {10.33425/2769-6294.1004}
}
Kostenlos starten →